The novel HLA‐B *49:81 allele characterized by next‐generation sequencing
HLA · 2024
DOI: 10.1111/tan.15275 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Anastasiia Ananeva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russia. Hauptthemen laut MEDLINE: Genes, MHC Class I, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 2 Literaturangaben. Gefördert von: Charity fund «National Bone Marrow Donors Registry named after Vasya Perevoshchikov», Kazan Federal University Strategic Academic Leadership Program.
Abstract (Originalsprache)
The novel HLA‐B*49:81 allele differs by one nucleotide change from HLA‐B*49:01:01.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russia.
- National Bone Marrow Donors Registry Named After Vasya Perevoshchikov, Moscow, Russia.
- Loginov Moscow Clinical Scientific Center, Moscow, Russia.
ORCID-Profile: Anastasiia Ananeva, Elena I Shagimardanova
Förderung
- Charity fund «National Bone Marrow Donors Registry named after Vasya Perevoshchikov»
- Kazan Federal University Strategic Academic Leadership Program
Zitieren
APA
Ananeva, A., Akhmetshina, G., Andryushkina, A. V., & Shagimardanova, E. I. (2024). The novel HLA‐B *49:81 allele characterized by next‐generation sequencing. HLA. https://doi.org/10.1111/tan.15275
Vancouver
Ananeva A, Akhmetshina G, Andryushkina AV, Shagimardanova EI. The novel HLA‐B *49:81 allele characterized by next‐generation sequencing. HLA. 2024. doi:10.1111/tan.15275
BibTeX
@article{Ananeva2024,
author = {Ananeva, Anastasiia and Akhmetshina, Gulnaz and Andryushkina, Anna V and Shagimardanova, Elena I},
title = {The novel HLA‐B *49:81 allele characterized by next‐generation sequencing},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15275}
}
EUVIMED